Hepatitis C – a chronic infection affecting an estimated 230,000 Australians – is one of the most common notifiable diseases in Australia. If left untreated, hepatitis C can cause liver inflammation, scarring and thickening (cirrhosis), liver failure, and liver cancer.
However, more curative treatments than ever before are now available on the PBS for hepatitis C.
The latest Australian Bureau of Statistics (ABS) figures reveal Australians born in Arabic nations from across the Middle East and North Africa (374,083) now represent almost two per cent of the Australian population. In Arabic countries, 3.5 per cent of the population is estimated to have hepatitis C, making Arabic-born Australians a key demographic in the Federal Government’s quest to increase the number of people receiving treatment by 50 per cent each year.
Dr Magdy Ramzy explains the risks, ways of infection, and the treatment.
حمّل تطبيق أس بي أس الجديد للإستماع لبرامجكم المفضلة باللغة العربية.
